To support research and study purposes, we supply a range of NGAL ELISA kits which are compatible with commonly used models:
Medical Research: NGAL is up-regulated dramatically in damaged renal tubular cells and passes from the tubular cells into both urine and blood. NGAL changes in these fluids can be used to assess kidney status as a supplement to other established medical products or procedures.
Clinical Trials: Drug-induced acute kidney injury account for as much as 25% of all episodes of acute renal failure – a serious problem in clinical medicine as well as in the pharmaceutical industry. In drug development, some therapeutic candidates fail due to unexpected toxic effects in the kidneys, resulting in adverse outcomes and ultimately development termination of these candidates (attrition). The use of NGAL as part of a biomarker panel during a preclinical drug selection strategy in drug development aids the selection of the most promising drug candidates.
In order to provide the best possible support to researchers in the nephrotoxicity arena, BioPorto supply a wide range of ELISA based kits for NGAL measurement for use in both animal and human systems.